Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 13 results:
Συντάκτης Τίτλος [ Τύπος(Asc)] Έτος
Φίλτρα: Keyword is Death, Sudden, Cardiac  [Clear All Filters]
Journal Article
Savopoulos, C., Ntaios G., & Hatzitolios A. (2009).  Is there a geographic variation in the seasonal distribution of acute myocardial infarction and sudden cardiac death?. Int J Cardiol. 135(2), 253-4.
Efthimiadis, G. K., Pagourelias E. D., Meditskou S., Pliakos C., Styliadis I. H., & Parcharidis G. E. (2009).  Sudden death after alcohol septal ablation in hypertrophic cardiomyopathy.. Am J Cardiol. 104(5), 743.
Deligiannis, A., Anastasakis A., Antoniades L., Bobotis G., Geleris P., Goudevenos J., et al. (2010).  Recommendations for the cardiovascular screening of athletes.. Hellenic J Cardiol. 51(6), 530-7.
Pagourelias, E. D., Efthimiadis G. K., Parcharidou D. G., Gossios T. D., Kamperidis V., Karoulas T., et al. (2011).  Prognostic value of right ventricular diastolic function indices in hypertrophic cardiomyopathy.. Eur J Echocardiogr. 12(11), 809-17.
Gatzoulis, K. A., Tsiachris D., Arsenos P., Dilaveris P., Sideris S., Simantirakis E., et al. (2014).  Post myocardial infarction risk stratification for sudden cardiac death in patients with preserved ejection fraction: PRESERVE-EF study design.. Hellenic J Cardiol. 55(5), 361-8.
Efthimiadis, G. K., Zegkos T., Meditskou S., & Hadjimiltiades S. (2014).  Perspectives on sudden death prevention in hypertrophic cardiomyopathy.. Cardiol Rev. 22(5), 210-6.
Efthimiadis, G. K., Parcharidou D. G., Giannakoulas G., Pagourelias E. D., Charalampidis P., Savvopoulos G., et al. (2009).  Left ventricular outflow tract obstruction as a risk factor for sudden cardiac death in hypertrophic cardiomyopathy.. Am J Cardiol. 104(5), 695-9.
Konstantinou, D. M., Efthimiadis G. K., Vassilikos V., Paraskevaidis S., Pagourelias E., Maron B. J., et al. (2016).  Implantable cardioverter defibrillators for primary prevention of sudden death in hypertrophic cardiomyopathy.. J Cardiovasc Med (Hagerstown). 17(6), 433-9.
Makavos, G., Κairis C., Tselegkidi M-E., Karamitsos T., Rigopoulos A. G., Noutsias M., et al. (2019).  Hypertrophic cardiomyopathy: an updated review on diagnosis, prognosis, and treatment.. Heart Fail Rev. 24(4), 439-459.
Kouidi, E. J., Grekas D. M., & Deligiannis A. P. (2009).  Effects of exercise training on noninvasive cardiac measures in patients undergoing long-term hemodialysis: a randomized controlled trial.. Am J Kidney Dis. 54(3), 511-21.
Efthimiadis, G. K., & Pagourelias E. D. (2009).  Delayed hyperenhancement magnetic resonance imaging for sudden cardiac death risk stratification in hypertrophic cardiomyopathy.. J Am Coll Cardiol. 55(1), 77.
Mehran, R., Baber U., Steg P. Gabriel, Ariti C., Weisz G., Witzenbichler B., et al. (2013).  Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study.. Lancet. 382(9906), 1714-22.
Kamperidis, V., Karamitsos T. D., Pappa Z., Nikolaidou O., & Karvounis H. (2019).  ALCAPA syndrome and risk of sudden death in young people.. QJM. 112(4), 291-292.

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές